VALUES FIRST ADVISORS, INC. AcelRx Pharmaceuticals, Inc. Transaction History

VALUES FIRST ADVISORS, INC. portfolio value:

$166,000
portfolio value

VALUES FIRST ADVISORS, INC. quarter portfolio value change:

-14.45%
quarter

AcelRx Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +3.52% 1.35K shares -21K $0.21 39.70K
Q2 2022 share Increase +19.40% 124.63K shares 4K $0.24 767.15K
Q1 2022 share Increase +23.73% 123.24K shares -108K $0.29 642.51K
Q4 2021 share Increase 0.00% 519.27K shares 291K $0.49 519.27K